Loading...All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
FGL1 (fibrinogen-like protein 1, also annotated as hepassocin) encodes a secreted protein belonging to the fibrinogen-related protein family, predominantly generated within hepatic tissue and additional vertebrate tissue compartments. This soluble protein comprises an N-terminal coiled-coil segment and a conserved C-terminal fibrinogen-like domain capable of mediating molecular interactions with corresponding receptor components. Following biosynthesis, newly synthesized FGL1 undergoes folding and endomembrane system quality control processing prior to secretion. Mature protein molecules are released into extracellular environments, while partial protein pools remain stored within intracellular vesicular compartments to sustain protein maturation, secretion and physiological protein turnover. Secreted abundance of FGL1 can be dynamically tuned to satisfy tissue specific immune modulation and metabolic homeostatic adaptive demands.
Within extracellular microenvironments, FGL1 is a soluble homodimer reported to interact with the extracellular region of LAG3. Complex stability and local protein abundance are modulated by biochemical microenvironments, shaping the scope of intermolecular communication. Perturbations to FGL1 structural integrity or expression magnitude may interfere with protein partner complex organisation and shift measurable readouts derived from fibrinogen-like protein mediated interaction studies. FGL1-LAG3 interactions have been linked to suppression of T-cell responses in defined experimental models. FGL1 has also been implicated in hepatic regeneration and metabolic regulation; these roles should not be attributed to direct binding of secreted FGL1 to intracellular regulatory partners. Genetic sequence alterations within the FGL1 coding locus may impair protein folding, partner binding interfaces and intermolecular coupling capacity. Closely related fibrinogen superfamily paralogues cannot fully reproduce FGL1 unique complex forming profiles and tissue distribution characteristics, even though partial functional overlap is proposed among subfamily members. Variations in FGL1 protein abundance correspond to cellular adaptive requirements for immune and metabolic dependent responses, rendering this secreted protein a valuable research subject for dissecting fibrinogen-family biology and extracellular immune homeostasis. FGL1-dependent effects vary with ligand state, receptor availability and the experimental system, rather than requiring an obligatory heteromeric subunit assembly. Its characteristic dimeric architecture and conserved fibrinogen-like domain differentiate FGL1 from numerous other secreted immune modulatory molecules, supporting ordered spatial organisation of protein complexes and mediating selective reversible contacts with diversified receptor moieties. Diminished functional competence of FGL1 may trigger disorganised protein partner complex arrangement and weaken tissue level immune regulatory related adaptive buffering capacity, highlighting its research relevance for secreted immune regulatory protein oriented laboratory investigations.
Fig. 1 Sequence alignment and structural architecture of FGL1. FGL1 monomer contains CCD and FD domains; two monomers form homodimer via disulfide linkage.1
The biological functions of secreted FGL1 fibrinogen-like protein 1 are focused on reported LAG3 binding and immune modulation, together with hepatic regenerative and metabolic functions that depend on the model context:
Creative Biolabs offers purified FGL1 protein samples generated under unified preparation workflows, including full length constructs and isolated domain truncated variants. Fibrinogen-like domain constructs may retain partner-binding activity, whereas the coiled-coil region and oligomeric state can influence molecular presentation. Construct suitability depends on the retained regions and research question. All batches receive uniform quality screening. Binding or functional studies require appropriate construct boundaries, ligand presentation and receptor-bearing models rather than full length as a universal criterion. Consistent structural features are preserved across batches to support comparative laboratory analysis across separate test groups. Full-length and domain constructs may support comparative binding studies, while receptor-dependent biological effects require separate evaluation.
Not finding the protein product you need? Contact us to start your one-stop custom service!
Creative Biolabs provides adjustable FGL1 expression cell research models with tunable target expression levels, applicable to structural observation of secreted fibrinogen-like regulatory protein and research into protein partner molecular interaction. Sample evaluation focuses on target expression; secretion and extracellular FGL1 levels require separate assessment. These cell systems can pair with laboratory analysis schemes for expression or conditioned-medium studies; receptor-dependent responses require a compatible target-cell system and cannot be inferred from FGL1 expression alone.
Not finding the stable cell line product you need? Contact us to start your one-stop custom service!
Anti-FGL1 recombinant antibodies are generated via standardized protein preparation workflows, compatible with routine laboratory detection techniques for protein localization mapping and identification of protein partner molecular complexes. The antibody series can work alongside common laboratory detection reagents to realise multi dimensional observation of target protein distribution within biological sample materials.
Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!
Beyond catalog products, Creative Biolabs offers specialized custom services for FGL1 research:
FGL1 might act as a secreted fibrinogen-related immune regulatory protein and participate in heteromeric partner complex assembly to modulate protein complex arrangement and immune modulation associated extracellular homeostasis.
FGL1 is a significant research target because of its reported interaction with LAG3 and its roles in hepatic regeneration and metabolic regulation. Defined research models are needed to distinguish these context-dependent functions.
No, FGL1 associated research reagents from Creative Biolabs are exclusively built for exploring FGL1-dependent extracellular regulatory mechanisms, and shall not be deployed for any clinical oriented workflows. These preparations are optimized for basic laboratory investigation and do not satisfy performance benchmarks required for clinical implementation.
Offerings include full length FGL1 protein, target specific recombinant antibodies and tunable expression cell research models, supporting research on immune modulation associated extracellular homeostasis and protein mediated partner perception.
Laboratory observation schemes may include protein partner interaction related tests to analyse molecular binding associated behaviours under simulated extracellular microenvironment conditions.